The Challenge of Caring for Multiple Patients With Cancer
As more new treatments enter practice—like immunotherapy, targeted therapy, and combination therapies—oncology nurses are required to be experts in every treatment they administer. They need to constantly walk a tightrope, balancing multiple medications for one patient then quickly moving to the next patient on a completely different treatment protocol.
The Case of the Omitted Opioid
Rocky is a 56-year-old man with stage III oropharyngeal cancer. He is undergoing concurrent chemotherapy and radiation. Rocky is a long-haul truck driver, has had sporadic medical care in the past, has no primary care provider, and usually visits the emergency department in whatever town he is in when he gets sick. He was diagnosed during one of those visits after an episode of hematemesis.
Research Gives Insight on Cognitive Function in Patients With Cancer
Poor cognitive function can cause distress, impact quality of life, and contribute to treatment non-adherence, Catherine Bender, PhD, RN, FAAN, from the University of Pittsburgh, explained during the Distinguished Nurse Researcher session at the 42nd Annual Congress in Denver, CO. She is the 2017 recipient of the Distinguished Nurse Research Award, which recognizes the contributions of a member who has conducted or promoted research that has enhanced the science and practice of oncology nursing.
Advisory Board Provides Input on Interventions to Help Older Adults Manage CINV
Chemotherapy-induced nausea and vomiting (CINV) can lead to serious adverse events (AEs) for older adults that could result in hospitalizations. Older adults may be overwhelmed with the amount of information involved with diagnosis and treatment, may not believe their actions will have an impact on symptoms, and tend to adopt a “wait and see” approach to managing AEs. Educational initiatives that tailor symptom management to older adults are necessary to engage and prepare these patients to self-mange CINV at home.
Navigating Medical Marijuana Laws and Use in Treatment
Medical marijuana laws still vary across the United States, and barriers persist for patients and providers, including fear of addiction and side effects as well as safety, financial, and legal concerns. Carey Clark, PhD, RN, AHN-BC, of the University of Maine at Augusta, Jacquelyn Bainbridge, PharmD, FCCP, from the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, and Lisa Kennedy Sheldon, PhD, APRN-BC, AOCNP®, FAAN, chief clinical officer at the Oncology Nursing Society, discussed the latest in medical marijuana laws and usage during a session at the 42nd Annual Congress in Denver, CO.
Using Patient-Reported Outcomes Improves Symptoms in Adults With Acute Leukemia
Ashley Bryant, PhD, RN, OCN®, assistant professor at the University of North Carolina at Chapel Hill School of Nursing, was the recipient of the 2017 Victoria Mock New Investigator Award and gave a lecture at the 42nd Annual Congress in Denver, CO, on her work on patient-reported symptoms and quality of life.
Study Finds Guideline Training and Reinforcement of CINV Knowledge Is Important
Chemotherapy-induced nausea and vomiting (CINV) is a side effect reported by 40%–80% of patients receiving cancer treatment. However, CINV can be prevented in 70%–80% of those cases with appropriate antiemetic prophylaxis. Few studies have evaluated approaches to improve provider adherence to antiemetic guidelines, and those who do adhere often have limited demonstrated success.
Disease Symptoms Most Likely to Predict Recurrence of Early-Stage Melanoma
Patients and healthcare providers are most likely to detect recurrence of early-stage melanoma based on symptom reports rather than routine imaging tests, according to the results of a study published in the Journal of the American College of Surgeons.
Physical Activity, Psychological Care Reduce Cancer-Related Fatigue
Physical activity, by itself or in combination with psychological care, was found to be most successful at reducing cancer-related fatigue (CRF) in patients, according to a study published in JAMA. The researchers compared the efficacy of four different types of CRF treatments—exercise, the combination of exercise and psychological treatments, psychological treatments alone, and pharmaceutical treatments—to determine the most effective treatment for CRF.
Antidepressant May Relieve Joint Pain From Aromatase Inhibitors
The antidepression drug duloxetine, which is approved to treat depression, anxiety, fibromyalgia, and diabetes nerve pain, may also relieve treatment-induced joint pain in breast cancer survivors receiving aromatase inhibitor therapy, according to the results of a study presented at the San Antonio Breast Cancer Symposium.